Show simple item record

Complement dependency of cardiomyocyte release of mediators during sepsis

dc.contributor.authorAtefi, Gelareh
dc.contributor.authorZetoune, Firas S.
dc.contributor.authorHerron, Todd J.
dc.contributor.authorJalife, José
dc.contributor.authorBosmann, Markus
dc.contributor.authorAl‐aref, Rami
dc.contributor.authorSarma, J. Vidya
dc.contributor.authorWard, Peter A.
dc.date.accessioned2020-02-05T15:05:09Z
dc.date.available2020-02-05T15:05:09Z
dc.date.issued2011-07
dc.identifier.citationAtefi, Gelareh; Zetoune, Firas S.; Herron, Todd J.; Jalife, José ; Bosmann, Markus; Al‐aref, Rami ; Sarma, J. Vidya; Ward, Peter A. (2011). "Complement dependency of cardiomyocyte release of mediators during sepsis." The FASEB Journal 25(7): 2500-2508.
dc.identifier.issn0892-6638
dc.identifier.issn1530-6860
dc.identifier.urihttps://hdl.handle.net/2027.42/153592
dc.description.abstractWe have recently shown that antibodyâ induced blockade of C5a, C5a receptors, or ILâ 17A greatly reduced the harmful outcomes of sepsis. In the current study, normal cardiomyocytes from young (300 g) male Spragueâ Dawley rats responded in vitro to C5a (ED50=55 nM) with release of ILâ 6 and TNFα, peaking between 2 to 8 h. Neutralizing antibodies to mouse C5a or ILâ 17A (ED50=40 μg for each, based on improved survival) reduced spontaneous in vitro release of cardiosuppressive cytokines and chemokines in cardiomyocytes obtained from mice with polymicrobial sepsis. A nonâ neutralizing C5a antibody had no such effects. Cardiomyocytes from septic mice (C57Bl/6) showed increased mRNA for TNFR1, ILâ 6 (gp80), and C5aR at 6 h after sepsis. Cardiomyocytes from septic C5aRâ /â or C5L2â /â mice did not show spontaneous in vitro release of cytokines and chemokines. These data suggest that cardiomyocytes from septic mice release suppressive cytokines in a C5aâ , C5aRâ , and ILâ 17Aâ dependent manner, followed by mediator reactivity with receptors on cardiomyocytes, resulting in defective contractility and relaxation. These data may be relevant to a strategy for the treatment of heart dysfunction developing during sepsis.â Atefi, G., Zetoune, F. S., Herron, T. J., Jalife, J., Bosmann, M., Chen, A., Alâ Aref, R., Sarma, J. V., Ward, P. A. Complement dependency of cardiomyocyte release of mediators during sepsis. FASEB J. 25, 2500â 2508 (2011). www.fasebj.org
dc.publisherWiley Periodicals, Inc.
dc.subject.othercytokines
dc.subject.otherC5a
dc.subject.otherILâ 17A
dc.subject.othercardiomyopathy
dc.subject.othercytokine receptors
dc.titleComplement dependency of cardiomyocyte release of mediators during sepsis
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelBiology
dc.subject.hlbtoplevelScience
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/153592/1/fsb2025007040.pdf
dc.identifier.doi10.1096/fj.11-183236
dc.identifier.sourceThe FASEB Journal
dc.identifier.citedreferenceFlierl, M. A., Rittirsch, D., Gao, H., Hoesel, L. M., Nadeau, B. A., Day, D. E., Zetoune, F. S., Sarma, J. V., Huberâ Lang, M. S., Ferrara, J. L., and Ward, P. A. ( 2008 ) Adverse functions of ILâ 17A in experimental sepsis. FASEB J. 22, 2198 â 2205
dc.identifier.citedreferenceRittirsch, D., Flierl, M. A., and Ward, P. A. ( 2008 ) Harmful molecular mechanisms in sepsis. Nat. Rev. Immunol. 8, 776 â 787
dc.identifier.citedreferenceParrillo, J. E., Burch, C., Shelhamer, J. H., Parker, M. M., Natanson, C., and Schuette, W. ( 1985 ) A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J. Clin. Invest. 76, 1539 â 1553
dc.identifier.citedreferenceCrouser, E. D. ( 2004 ) Mitochondrial dysfunction in septic shock and multiple organ dysfunction syndrome. Mitochondrion 4, 729 â 741
dc.identifier.citedreferenceGellerich, F. N., Trumbeckaite, S., Opalka, J. R., Gellerich, J. F., Chen, Y., Neuhof, C., Redl, H., Werdan, K., and Zierz, S. ( 2002 ) Mitochondrial dysfunction in sepsis: evidence from bacteraemic baboons and endotoxaemic rabbits. Biosci. Rep. 22, 99 â 113
dc.identifier.citedreferenceBrealey, D., Brand, M., Hargreaves, I., Heales, S., Land, J., Smolenski, R., Davies, N. A., Cooper, C. E., and Singer, M. ( 2002 ) Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 360, 219 â 223
dc.identifier.citedreferenceHarrois, A., Huet, O., and Duranteau, J. ( 2009 ) Alterations of mitochondrial function in sepsis and critical illness. Curr. Opin. Anaesthesiol. 22, 143 â 149
dc.identifier.citedreferenceFlierl, M. A., Rittirsch, D., Huberâ Lang, M. S., Sarma, J. V., and Ward, P. A. ( 2008 ) Molecular events in the cardiomyopathy of sepsis. Mol. Med. 14, 327 â 336
dc.identifier.citedreferenceJoulin, O., Petillot, P., Labalette, M., Lancel, S., and Neviere, R. ( 2007 ) Cytokine profile of human septic shock serum inducing cardiomyocyte contractile dysfunction. Physiol. Res. 56, 291 â 297
dc.identifier.citedreferenceCain, B. S., Meldrum, D. R., Dinarello, C. A., Meng, X., Joo, K. S., Banerjee, A., and Harken, A. H. ( 1999 ) Tumor necrosis factorâ alpha and interleukinâ 1beta synergistically depress human myocardial function. Crit. Care Med. 27, 1309 â 1318
dc.identifier.citedreferenceJanssen, S. P., Gayanâ Ramirez, G., Van den Bergh, A., Herijgers, P., Maes, K., Verbeken, E., and Decramer, M. ( 2005 ) Interleukinâ 6 causes myocardial failure and skeletal muscle atrophy in rats. Circulation 111, 996 â 1005
dc.identifier.citedreferenceKumar, A., Paladugu, B., Mensing, J., and Parrillo, J. E. ( 2007 ) Transforming growth factorâ beta1 blocks in vitro cardiac myocyte depression induced by tumor necrosis factorâ alpha, interleukinâ 1beta, and human septic shock serum. Crit. Care Med. 35, 358 â 364
dc.identifier.citedreferenceMaass, D. L., White, J., and Horton, J. W. ( 2002 ) ILâ 1beta and ILâ 6 act synergistically with TNFâ alpha to alter cardiac contractile function after burn trauma. Shock 18, 360 â 366
dc.identifier.citedreferenceMaass, D. L., Hybki, D. P., White, J., and Horton, J. W. ( 2002 ) The time course of cardiac NFâ kappaB activation and TNFâ alpha secretion by cardiac myocytes after burn injury: contribution to burnâ related cardiac contractile dysfunction. Shock 17, 293 â 299
dc.identifier.citedreferenceNiederbichler, A. D., Hoesel, L. M., Westfall, M. V., Gao, H., Ipaktchi, K. R., Sun, L., Zetoune, F. S., Su, G. L., Arbabi, S., Sarma, J. V., Wang, S. C., Hemmila, M. R., and Ward, P. A. ( 2006 ) An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction. J. Exp. Med. 203, 53 â 61
dc.identifier.citedreferenceRittirsch, D., Huberâ Lang, M. S., Flierl, M. A., and Ward, P. A. ( 2009 ) Immunodesign of experimental sepsis by cecal ligation and puncture. Nat. Protoc. 4, 31 â 36
dc.identifier.citedreferenceHuberâ Lang, M. S., Sarma, J. V., McGuire, S. R., Lu, K. T., Guo, R. F., Padgaonkar, V. A., Younkin, E. M., Laudes, I. J., Riedemann, N. C., Younger, J. G., and Ward, P. A. ( 2001 ) Protective effects of antiâ C5a peptide antibodies in experimental sepsis. FASEB J. 15, 568 â 570
dc.identifier.citedreferenceRittirsch, D., Flierl, M. A., Nadeau, B. A., Day, D. E., Huberâ Lang, M., Mackay, C. R., Zetoune, F. S., Gerard, N. P., Cianflone, K., Kohl, J., Gerard, C., Sarma, J. V., and Ward, P. A. ( 2008 ) Functional roles for C5a receptors in sepsis. Nat. Med. 14, 551 â 557
dc.identifier.citedreferenceHerron, T. J., Vandenboom, R., Fomicheva, E., Mundada, L., Edwards, T., and Metzger, J. M. ( 2007 ) Calciumâ independent negative inotropy by betaâ myosin heavy chain gene transfer in cardiac myocytes. Circ. Res. 100, 1182 â 1190
dc.identifier.citedreferenceSingh, M. V., Kapoun, A., Higgins, L., Kutschke, W., Thurman, J. M., Zhang, R., Singh, M., Yang, J., Guan, X., Lowe, J. S., Weiss, R. M., Zimmermann, K., Yull, F. E., Blackwell, T. S., Mohler, P. J., and Anderson, M. E. ( 2009 ) Ca2+/calmodulinâ dependent kinase II triggers cell membrane injury by inducing complement factor B gene expression in the mouse heart. J. Clin. Invest. 119, 986 â 996
dc.identifier.citedreferenceWard, P. A. ( 2009 ) The sepsis seesaw: seeking a heart salve. Nat. Med. 15, 497 â 498
dc.identifier.citedreferenceBuras, J. A., Rice, L., Orlow, D., Pavlides, S., Reenstra, W. R., Ceonzo, K., and Stahl, G. L. ( 2004 ) Inhibition of C5 or absence of C6 protects from sepsis mortality. Immunobiology 209, 629 â 635
dc.identifier.citedreferenceSoriano, F. G., Nogueira, A. C., Caldini, E. G., Lins, M. H., Teixeira, A. C., Cappi, S. B., Lotufo, P. A., Bernik, M. M., Zsengeller, Z., Chen, M., and Szabo, C. ( 2006 ) Potential role of poly(adenosine 5â ²â diphosphateâ ribose) polymerase activation in the pathogenesis of myocardial contractile dysfunction associated with human septic shock. Crit. Care Med. 34, 1073 â 1079
dc.identifier.citedreferencePacher, P., and Szabo, C. ( 2007 ) Role of poly(ADPâ ribose) polymerase 1 (PARPâ 1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors. Cardiovasc. Drug Rev. 25, 235 â 260
dc.identifier.citedreferenceCzermak, B. J., Sarma, V., Pierson, C. L., Warner, R. L., Huberâ Lang, M., Bless, N. M., Schmal, H., Friedl, H. P., and Ward, P. A. ( 1999 ) Protective effects of C5a blockade in sepsis. Nat. Med. 5, 788 â 792
dc.identifier.citedreferenceBallardâ Croft, C., Carlson, D., Maass, D. L., and Horton, J. W. ( 2004 ) Burn trauma alters calcium transporter protein expression in the heart. J. Appl. Physiol. 97, 1470 â 1476
dc.identifier.citedreferenceThompson, M., Kliewer, A., Maass, D., Becker, L., White, D. J., Bryant, D., Arteaga, G., Horton, J., and Giroir, B. P. ( 2000 ) Increased cardiomyocyte intracellular calcium during endotoxinâ induced cardiac dysfunction in guinea pigs. Pediatr. Res. 47, 669 â 676
dc.identifier.citedreferenceRabuel, C., and Mebazaa, A. ( 2006 ) Septic shock: a heart story since the 1960s. Intensive Care Med. 32, 799 â 807
dc.identifier.citedreferenceClowes, G. H., Jr., Vucinic, M., and Weidner, M. G. ( 1966 ) Circulatory and metabolic alterations associated with survival or death in peritonitis: clinical analysis of 25 cases. Ann. Surg. 163, 866 â 885
dc.identifier.citedreferenceBabuin, L., and Jaffe, A. S. ( 2005 ) Troponin: the biomarker of choice for the detection of cardiac injury. CMAJ 173, 1191 â 1202
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.